Rob Brown

Rob Brown is a MedTech executive and commercial development leader currently participating in an Executive Education Program at Harvard Business School. With extensive experience across various roles, including Chief Commercial Officer at Embody, Inc. and Principal at Incite Medica, Rob has a proven track record of transforming early-stage medical technologies into market-leading platforms. Most notably, Rob led the commercial strategy of Embody, which culminated in a successful acquisition by Zimmer Biomet. Throughout their career, Rob has demonstrated expertise in global market leadership, business development, and building high-performing teams in the medical device sector.